GSK’s Nigerian Unit to Close Down, Return Cash
GlaxoSmithKline Consumer Nigeria Plc, the second-biggest drug firm in the West African nation, will cease operations after its
2023-08-04 16:51
Moderna Raises Covid Shot Sales Guidance on Japan, US Pacts
Moderna Inc. raised its Covid-19 vaccine sales outlook for the year, finalizing contracts with Japan and several American
2023-08-03 22:27
China Drug-Price Negotiations Offers Glimpse Into Future for Companies in US
As drugmakers in the US steel for price negotiations ushered in by President Joe Biden’s Inflation Reduction Act,
2023-08-03 10:17
Merck Raises 2023 Sales Forecast as Cancer Drug Keytruda, Gardasil Vaccine Surge
Merck & Co.’s Keytruda and Gardasil soundly beat analysts’ estimates for quarterly sales, driving the company’s annual revenue
2023-08-01 19:25
Secret Deals With Russia Help Kim Jong Un Fund Nuclear Program
Reports of new types of sugar in the local markets. Satellite imagery of trains crossing borders. Cargo ships
2023-07-31 11:56
Biogen to Buy Reata for $7.3 Billion in Rare-Disease Deal
Biogen Inc. agreed to acquire Reata Pharmaceuticals Inc. for $7.3 billion, including debt, to expand its rare disease
2023-07-28 22:57
Bonds Extend Selloff as BOJ Tweaks Yield Control: Markets Wrap
Bonds around the world extended a retreat as the Bank of Japan, so far a holdout on ultra-loose
2023-07-28 16:58
Astra Strikes $1 Billion Gene Therapy Deal With Pfizer
AstraZeneca Plc has agreed to buy a portfolio of rare disease gene therapies from Pfizer Inc. as the
2023-07-28 15:27
Sanofi Lifts Guidance on Dupixent, Covid Vaccine Sales
Sanofi raised its forecast for the year as the French drugmaker gains new patients for blockbuster drug Dupixent
2023-07-28 13:52
North Korea Economy Shrinks Again as Pandemic Impact Drags On
North Korea’s economy shrank for a third year as the pandemic continued to weigh on activity, but resurgent
2023-07-28 11:17
Roche Signs $2.8 Billion Alnylam Deal for Hypertension Drug
Roche Holding AG will work together with Alnylam Pharmaceuticals Inc. on a potential treatment for high blood pressure
2023-07-24 16:49
Eye Disease Drugmaker’s Value Halved After Severe Reactions
Apellis Pharmaceuticals Inc. shares suffered their worst two-day drop on record after confirming reports that some patients experienced
2023-07-19 04:20